Rick Silva
Director of Technology Transfer for UCD

Rick Silva, PhD has over 8 years research experience and 6 years experience in biomedical commercialization. Dr. Silva works directly with TTO staff, CU faculty, and business leaders in the pharmaceutical and biotechnology industries to commercialize promising new biomedical products and technologies. His responsibilities include: general daily direction of the UCD biomedical commercialization enterprise; negotiation and review of UCD licensing and collaboration agreements, other IP related contracting activities like MTAs and sponsored research; working with CU business development in HSC startup company formation, development, financing, and strategy.

Dr. Silva’s areas of business/commercialization interest are preclinical drug development; inflammation and immunity; vaccine development; oncology; biomarkers and pharmacodiagnostics; translational medicine; seed financing and venture capital; business development.  He currently serves as Interim Director of Fitzsimons BioBusiness Partners Inc.

MBA; University of Colorado- Boulder; Finance and Entrepreneurship
Ph.D. Physiology; Colorado State University; Molecular and Reproductive Endocrinology
BS; Agriculture; New Mexico State University; Animal Science